These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9418168)

  • 1. Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
    Ghezzi S; Vicenzi E; Soldini L; Tambussi G; Murone M; Lazzarin A; Poli G
    J Biol Regul Homeost Agents; 1997; 11(1-2):74-8. PubMed ID: 9418168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic reconstitution by interleukin-2: facts and open questions.
    Vallanti G; Bovolenta C; Brambilla A; Tambussi G; Lazzarin A; Vicenzi E; Poli G
    J Biol Regul Homeost Agents; 2000; 14(1):41-4. PubMed ID: 10763892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2: from T cell growth and homeostasis to immune reconstitution of HIV patients.
    Kryworuchko M; Thèze J
    Vitam Horm; 2006; 74():531-47. PubMed ID: 17027529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why is IL-2 being considered?
    TreatmentUpdate; 1999 Mar; 11(2):2-3. PubMed ID: 11366775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2.
    Linnemeyer PA
    STEP Perspect; 1995; 7(1):6-7. PubMed ID: 11362400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational interleukins: the cutting edge of immune reconstitution.
    Whitfield L
    Posit Aware; 1998; 9(3):35-7. PubMed ID: 11365485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation with IL-2 and IL-12.
    Boonprakong L
    STEP Perspect; 1997; 9(1):9-12. PubMed ID: 11364273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outrunning HIV to protect immune defenses.
    Gilden D
    GMHC Treat Issues; 1996 Nov; 10(11):1-5. PubMed ID: 11364008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.